Journey Medical annual debt-to-equity ratio
2020
2021
2022
2023
2024
2025
Journey Medical Debt-to-Equity Ratio Growth & History (DERM)
Journey Medical's debt-to-equity ratio was 0.80 for fiscal 2025.
View full Journey Medical company overviewJourney Medical annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.80 | −0.45 | −36.20% |
| 2024 | 2024-12-31 | 1.25 | 0.53 | +72.65% |
| 2023 | 2023-12-31 | 0.72 | −0.45 | −38.59% |
| 2022 | 2022-12-31 | 1.18 | 1.18 | +50468.23% |
| 2021 | 2021-12-31 | 0.00 | −0.02 | −86.82% |
| 2020 | 2020-12-31 | 0.02 | — | — |
Journey Medical quarterly debt-to-equity ratio
Q4.20
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.80 | −0.52 | −39.44% |
| Q1 2026 | 2026-03-31 | 0.83 | −0.34 | −29.30% |
| Q4 2025 | 2025-12-31 | 0.80 | −0.45 | −36.20% |
| Q3 2025 | 2025-09-30 | 0.98 | −0.84 | −46.14% |
| Q2 2025 | 2025-06-30 | 1.31 | −0.44 | −25.11% |
| Q1 2025 | 2025-03-31 | 1.17 | 0.03 | +2.46% |
| Q4 2024 | 2024-12-31 | 1.25 | 0.53 | +72.65% |
| Q3 2024 | 2024-09-30 | 1.81 | 1.81 | +23957.42% |
| Q2 2024 | 2024-06-30 | 1.75 | — | — |
| Q1 2024 | 2024-03-31 | 1.14 | — | — |
| Q4 2023 | 2023-12-31 | 0.72 | −0.45 | −38.59% |
| Q3 2023 | 2023-09-30 | 0.01 | −0.75 | −99.00% |
| Q4 2022 | 2022-12-31 | 1.18 | 1.18 | +50468.23% |
| Q3 2022 | 2022-09-30 | 0.76 | — | — |
| Q2 2022 | 2022-06-30 | 0.43 | — | — |
| Q1 2022 | 2022-03-31 | 0.36 | — | — |
| Q4 2021 | 2021-12-31 | 0.00 | −0.02 | −86.82% |
| Q4 2020 | 2020-12-31 | 0.02 | — | — |
Journey Medical debt-to-equity ratio trends
Over the last five fiscal years, Journey Medical's debt-to-equity ratio increased from 0.02 to 0.80, a change of 0.78. The latest reported quarter, Q2 2026, shows 0.80.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Journey Medical source filings ↗